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Abstract
Studies of persons living with HIV (PLWH) have compared current non-drinkers to at-risk 
drinkers without differentiating whether current non-drinkers had a prior alcohol use disorder 
(AUD). The purpose of this study was to compare current non-drinkers with and without a prior 
AUD on demographic and clinical characteristics to understand the impact of combining them. We 
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included data from 6 sites across the US from 1/2013–3/2015. Patients completed tablet-based 
clinical assessments at routine clinic appointments using the most recent assessment. Current non-
drinkers were identified by AUDIT-C scores of 0. We identified a prior probable AUD by a prior 
AUD diagnosis in the electronic medical record (EMR) or a report of attendance at alcohol 
treatment in the clinical assessment. We used multivariate logistic regression to examine factors 
associated with prior AUD. Among 2235 PLWH who were current non-drinkers, 36% had a prior 
AUD with more patients with an AUD identified by the clinical assessment than the EMR. Higher 
proportions with a prior AUD were male, depressed, and reported current drug use compared to 
non-drinkers without a prior AUD. Former cocaine/crack (70% vs. 25%), methamphetamine/
crystal (49% vs. 16%) and opioid/heroin use (35% vs. 7%) were more commonly reported by 
those with a prior AUD. In adjusted analyses, male sex, past methamphetamine/crystal use, past 
marijuana use, past opioid/heroin use, past and current cocaine/crack use and cigarette use were 
associated with a prior AUD. In conclusion, this study found that among non-drinking PLWH in 
routine clinical care, 36% had a prior AUD. We found key differences between those with and 
without prior AUD in demographic and clinical characteristics including drug use and depression. 
These results suggest non-drinkers are heterogeneous and need further differentiation in studies 
and that prior alcohol misuse including alcohol treatment should be included in behavioral health 
assessments as part of clinical care.
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Introduction
General population studies suggest non-drinkers and heavy alcohol drinkers have worse 
outcomes compared with light-to-moderate drinkers(G. Corrao, Rubbiati, Bagnardi, 
Zambon, & Poikolainen, 2000; Ronksley, Brien, Turner, Mukamal, & Ghali, 2011), referred 
to as “abstainer effect”(Lucas, Windsor, Caldwell, & Rodgers, 2010) resulting in a J- or U-
shaped outcome curve(Shaper, Wannamethee, & Walker, 1988). It has been argued that these 
findings are due in part to misclassification, particularly of former drinkers in the non-
drinker category, mixing lifetime abstainers with those with prior alcohol use who may have 
quit because of poor health, aging, and other reasons(Sareen, McWilliams, Cox, & Stein, 
2004; Shaper et al., 1988).
At-risk alcohol use including alcohol use disorders (AUD) among persons living with HIV 
(PLWH) has been associated with poor outcomes(Cook et al., 2001; Kim et al., 2014). Many 
studies among PLWH have compared health outcomes of non-drinkers to at-risk drinkers 
treating current nondrinkers as a homogeneous group. Thus, former drinkers are combined 
with lifelong nondrinkers regardless of whether former drinkers had a prior AUD. This 
potentially leads to increased risk in the nondrinker category for a variety of outcomes and 
an underestimate of the impact of alcohol.
This study evaluated the common practice of defining a non-drinker based on current 
alcohol use. We hypothesized that prior AUD would be common among current non-
Crane et al. Page 2













drinkers and that those with and without a prior AUD would differ. Specifically, among 
PLWH who are current nondrinkers, we used two approaches to identify prior AUD and 
compared demographic and clinical characteristics among current non-drinkers with and 
without a prior AUD.
Methods
Centers for AIDS Research Network of Integrated Clinical Systems (CNICS)
CNICS is a longitudinal observational study of PLWH receiving care from 8 clinical sites 
across the United States from 1/1/1995 to the present(Kitahata et al., 2008) of whom 6 
contributed data to these analyses (University of Washington, Seattle; University of 
Alabama, Birmingham; University of North Carolina, Chapel Hill; University of California, 
San Francisco; University of California, San Diego; Fenway Health, Boston).
Study Subjects
All PLWH ≥18 years of age who completed a clinical assessment of patient reported 
behaviors and outcomes between 1/2013–3/2015 and reported they were currently not 
drinking were eligible. Individuals not receiving antiretroviral therapy (ART) were excluded 
from adherence analyses. The clinical assessment is completed every ~4–6 months during 
routine clinical visits. For those who completed multiple assessments during the study 
period, the most recent assessment was used. PLWH who are medically unstable, appear 
intoxicated, have a cognitive impairment, or do not speak English, Spanish or Amharic are 
not asked to complete the assessment at that visit. CNICS was approved by each site’s 
Institutional Review Board.
Data Sources
The CNICS data repository integrates longitudinal data including comprehensive clinical 
data from outpatient and inpatient encounters such as standardized HIV-related information 
collected at enrollment (initial clinic visit), demographic, clinical, medication, laboratory, 
and socioeconomic data obtained from each site’s electronic medical record (EMR) and 
other institutional data sources.
Patients used touch-screen tablets to complete the ~10–12 minute clinical assessment 
including measures of alcohol use (Alcohol Use Disorders Identification Test, AUDIT-C)
(Bradley et al., 2003) and alcohol treatment or attending Alcohol Anonymous for an alcohol 
problem(Bradley et al., 2004), substance use (modified Alcohol, Smoking, and Substance 
Involvement Screening Test [ASSIST])(Newcombe, Humeniuk, & Ali, 2005, 2002), and 
depressive symptoms (Patient Health Questionnaire [PHQ-9])(Spitzer, Kroenke, & 
Williams, 1999). ART adherence is measured by a 30-day visual analog scale item (VAS)
(Amico et al., 2006), a 30-day self-rating item(Feldman et al., 2012; Lu et al., 2008), and by 
items from the Adult AIDS Clinical Trial Group (AACTG) adherence measure including an 
item on time since last missed dose(Chesney et al., 2000).
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AUDIT-C measures current alcohol use over the prior year. PLWH who were current non-
drinkers were identified by AUDIT-C scores of 0. The ASSIST categorizes drug use as 
current (past 3 months), prior, or never(Newcombe et al., 2005, 2002). We examined drug 
use defined by 1) type of drug (marijuana, crack/cocaine, methamphetamines/crystal, or 
illicit opioid/heroin); 2) any drug use; and 3) any drug use excluding marijuana. Cigarette 
use was categorized as current, prior, or never. Depressive symptom scores from the PHQ-9 
range from 0–27 and were categorized as: none (0–4), mild (5–9), moderate (10–19), or 
severe (≥20 points) or as a binary outcome: not depressed (0–9), depressed (≥10)(Kroenke, 
Spitzer, & Williams, 2001). Approximately 2% had incomplete data for substance use or 
depression and these individuals were categorized based on whatever portion of items they 
had completed. The VAS adherence measure provides a percentage of doses taken.
Prior at-risk drinkers
We used two strategies to identify those with a probable prior AUD. First, from the EMR, 
we identified individuals who were previously diagnosed with an AUD. Second, we 
identified individuals who reported on the clinical assessment that they had been in alcohol 
treatment or attended Alcoholics Anonymous (AA) for an alcohol problem(Bradley et al., 
2004). Either strategy was sufficient to meet criteria for a prior AUD.
Statistical Analyses
We performed chi-squared tests to compare those with and without a prior AUD. We 
examined demographic characteristics including age, race/ethnicity, sex, risk factor for HIV 
transmission; and clinical characteristics including CD4+ cell count nadir, current CD4+ cell 
count, current HIV-1 RNA viral load level (detectable vs. undetectable), current ART use, 
hepatitis C virus (HCV) infection indicated by the presence of HCV antibody or HCV RNA, 
depression category, and substance use (both overall and by individual drug class). We 
examined the percentage of current non-drinking PLWH by demographic and clinical 
categories with and without prior AUD.
We compared adherence among the subset on ART. We hypothesized that among current 
non-drinkers, those with a prior AUD would have lower adherence than those without a prior 
AUD.
We used multivariate logistic regression to examine factors associated with prior AUD. 
Inclusion in models was based on bivariate results, potential confounders, and hypotheses 
such as those with prior AUD would have more severe HIV disease measured by CD4 and 
viral load values. Final models including age, race, sex, HIV transmission risk factor, CD4+ 
cell count nadir, viral load, HCV, depression, methamphetamine/crystal use, cocaine/crack 
use, illicit opioid/heroin use, marijuana use, and cigarette use.
Results
We included 2235 PLWH who reported that they currently did not drink. Mean age was 48 
years (standard deviation [SD] 10), 22% were women, and mean CD4+ count nadir was 263 
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(SD 228) cells/mm3. Among PLWH who did not currently drink, 36% had a prior probable 
AUD by the two approaches, specifically 12% had prior AUD diagnoses in the EMR, 31% 
reported having attended alcohol treatment or AA meetings, (7% had a prior AUD by both 
definitions)(Table 1).
Those with a prior AUD differed on demographic and clinical characteristics from those 
without a prior AUD (Table 2). Higher proportions with a prior AUD were male (85% vs. 
75%, p<0.001), white (54% vs. 38%, p<0.001), and depressed (29% vs. 22%, p<0.001). 
Those with a prior AUD were more likely to be co-infected with HCV (29% vs. 13%, 
p<0.001).
Higher proportions with a prior AUD had injected drugs (41% vs. 12%, p<0.001), and 
reported past (59% vs. 28%) and current (30% vs. 22%, p<0.001) drug use compared with 
those without a prior AUD (Table 3). Former methamphetamine/crystal use (49% vs. 16%), 
cocaine/crack (70% vs. 25%), opioid/heroin use (35% vs. 7%), and marijuana use (60% vs. 
29%) were more commonly reported by those with than those without a prior AUD (Table 
3).
Among 1993 PLWH on ART, adherence was not significantly lower in those with a prior 
AUD compared with those without (92% vs. 93%, p=0.4) by the VAS. The self-rating 
adherence item measure also did not differ between the two groups (p=0.1). Adherence 
measured by an item asking about last missed dose of medications did differ: those without a 
prior AUD were more likely to report that they “never skip medications” (51% vs. 36%, 
<0.001).
Furthermore, the percentage with an undetectable viral load was high in both groups (87% 
vs. 83% among those with and without a prior AUD). Current CD4+ counts and currently 
receiving ART were not statistically different between those with and without a prior AUD 
(Table 2).
Factors associated with a prior AUD
In adjusted logistic regression analyses, former methamphetamine/crystal use, former 
marijuana use, and former opioid/heroin use were all associated with a prior AUD. Both 
former and current cocaine/crack use and former and current cigarette use were also 
associated with a prior AUD (Table 4).
Discussion
Among 2235 PLWH in clinical care across the US who were currently not drinking, a third 
had a prior probable AUD. Self-reported alcohol treatment history captured more prior AUD 
than AUD diagnoses suggesting the importance of collecting this information from patients 
and not just relying on EMR diagnosis data. Non-drinkers with a prior AUD differed in 
demographic and clinical characteristics from those without a prior AUD. In particular, they 
were much more likely to report former and current cocaine/crack and cigarette use and 
former methamphetamine/crystal, opioid/heroin, and marijuana use. The proportion with 
prior drug use was more than twice as high for 4 drug classes among those with a prior 
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AUD. These results have important implications for studies of PLWH that compare current 
non-drinkers to at-risk drinkers without differentiating whether non-drinkers had a previous 
AUD or not.
“Sick quitter” hypothesis
In the general population, studies have examined associations between alcohol use and 
health outcomes and found lower risks among light-to-moderate drinkers compared to 
nondrinkers or heavy drinkers(Giovanni Corrao, Bagnardi, Zambon, & La Vecchia, 2004; 
Poikolainen, 1995) as has a recent study in PLWH(Wandeler et al., 2015). While few studies 
have separated former drinkers from nondrinkers or focused on lifetime use(Gmel, Gutjahr, 
& Rehm, 2003; Sareen et al., 2004), many have combined former drinkers with lifetime 
abstainers(K. Fillmore, Kerr, Stockwell, Chikritzhs, & Bostrom, 2006; K. M. Fillmore, 
Stockwell, Chikritzhs, Bostrom, & Kerr, 2007). A meta-analysis suggested that it is 
preferable to distinguish former drinkers from lifetime abstainers, although failing to do so 
caused minimal bias in the setting of myocardial infarction(Maclure, 1993). Other studies 
have suggested that former drinkers differ from lifetime abstainers(K. M. Fillmore et al., 
1998), and that the impact of conflating abstainers with former drinkers may be responsible 
for spurious associations of poorer health outcomes among nondrinkers(K. Fillmore et al., 
2006). Explanations have often focused on the “sick quitter hypothesis” in which findings 
are potentially being driven in part by previously heavy drinkers who became current non-
drinkers(Liang & Chikritzhs, 2013; Shaper, 1995). Some may quit drinking due to health 
reasons such as disability, frailty, and medication use(K. Fillmore et al., 2006). Thus, 
reference groups that combine lifetime non-drinkers with prior heavy drinkers who no 
longer drink may result in a reference group that distorts the health consequences associated 
with alcohol use(Dawson, Goldstein, & Grant, 2013). Those with prior heavy alcohol use 
who are currently non-drinkers have been shown to have worse outcomes than long-term 
non-drinkers(Gmel et al., 2003), however excluding current non-drinkers with heavy 
drinking histories from analyses has not always yielded consistent results(Lucas et al., 2010) 
with some studies showing that separating these patients from nondrinkers has substantial 
impact(K. Fillmore et al., 2006; Sareen et al., 2004) and others demonstrating an effect 
persisted even after excluding non-drinkers with prior heavy drinking(Alati et al., 2005; 
Power, Rodgers, & Hope, 1998).
The best approach to dealing with former drinkers is not clear and might vary based on 
outcomes although the common approach of combining them with other current non-
drinkers seems problematic. It has been argued that they cannot be combined with lifelong 
abstainers(K. M. Fillmore et al., 2007), and maybe even should be assigned to a drinking 
category based on prior alcohol consumption(Liang & Chikritzhs, 2013). We examined non-
drinking PLWH and found higher rates of former drinkers than seen in the general 
population(Dawson, 2000; Klatsky, Armstrong, & Friedman, 1990; Lucas et al., 2010). This 
high prevalence suggests that the impact of these former drinkers will persist if not be a 
bigger problem in studies of PLWH versus general population studies.
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This study focused on prior AUD based on alcohol treatment or AUD diagnoses among 
current non-drinkers which may be capturing patients with histories of more severe alcohol 
misuse. This may be a “tip of the iceberg” effect identifying the most extreme prior drinkers 
and yet this was still a third of non-drinking PLWH.
We used two approaches to identify prior AUD among PLWH. More PLWH with prior AUD 
were identified using patient reports of alcohol treatment from the clinical assessment than 
were identified by AUD diagnoses from the EMR, although there was overlap. While 
additional studies are needed to better understand the strengths and limitations of these 
approaches, using them both resulted in identifying more prior AUD among current non-
drinkers. Furthermore, those with prior AUD were a very distinct population from other non-
drinking PLWH, raising concerns about combining the two groups. For example, PLWH 
who were non-drinkers with prior AUD had on average a much more extensive substance 
use history than those without a prior AUD. Additional research is needed to examine the 
extent that separating non-drinking individuals with prior AUD from others who do not 
drink will impact studies of clinical outcomes such as myocardial infarction, liver disease 
and other outcomes of increasing importance for individuals aging with HIV. Furthermore, 
these findings highlight the need for careful review of prior alcohol use among current non-
drinkers including diagnoses and treatment history.
Adherence and other HIV Outcomes
We compared likelihood of being on ART, ART adherence, and having an undetectable viral 
load among current non-drinkers with and without a prior AUD. While current alcohol use is 
associated with poorer adherence(Chander, Lau, & Moore, 2006), this analysis looked at 
prior AUD among PLWH who currently did not drink and were on ART. Using three 
approaches to measuring self-reported adherence, two found no difference and one only 
differed among those at the extreme end of excellent adherence. This suggests there is not a 
substantial impact of prior AUD on adherence among current non-drinking PLWH, 
mirroring an extensive literature reporting on comparable adherence outcomes for patients 
with past or treated substance use disorder. In fact, adherence levels were high in both 
groups. While this raises a concern of over-reporting as adherence is a self-report measure, 
this concern is minimized by the corresponding high levels of undetectable viral loads. 
Similarly there were not large differences in the likelihood of receiving ART between those 
with and without a prior AUD.
This data suggests that there are a large proportion of PLWH currently in recovery with a 
third of current non-drinkers having a prior AUD many of whom are also in recovery from 
drugs. Furthermore, it demonstrates that these individuals have good HIV-related outcomes 
including ART access, adherence, and viral suppression providing more evidence of the 
benefits of getting individuals into recovery as another mechanism to improve HIV 
outcomes. This study does not address the impact of a prior AUD on other HIV-related 
outcomes including liver disease, cancer, cognitive decline, and frailty suggesting that there 
remain many unanswered questions.
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A strength of this study is that it was conducted in a large, diverse cohort with substantial 
numbers of women, racial/ethnic diversity, and a population increasing in mean age. This 
cohort exemplifies the changing epidemiology of HIV across the US. The clinical 
assessment integrated into routine care facilitated an assessment of current alcohol use as 
well as a prior AUD requiring alcohol treatment. Patients completed the clinical assessment 
as part of routine visits rather than as part of a specific study with study specific exclusion 
criteria enhancing generalizability to PLWH in care across the US. The comprehensive 
clinical data allowed AUD diagnoses in the EMR to be examined as an indicator of prior 
AUD. Another strength is that by focusing on 2013 and after, this study examines 
relationships in the current treatment era. Finally, the comprehensive measurement of not 
just alcohol but other drug use allows assessment of the role of individual drugs among 
PLWH who often do not limit their substance use to alcohol.
Limitations
This study has limitations. We evaluated associations with prior AUD, but associations do 
not necessarily indicate causation. Current alcohol use was collected via the clinical 
assessment which could lead to overestimates of PLWH who are current non-drinkers. 
However, electronic collection reduces patient burden and decreases underreporting of risk 
behaviors due to social desirability bias(Fairley, Sze, Vodstrcil, & Chen, 2010). Rather than 
formally assessing lifetime AUD diagnoses, we relied on patient report of prior treatment 
and provider generated AUD EMR diagnoses. Both methods could under- or over-estimate 
actual lifetime AUD. EMR diagnoses likely miss cases and it is possible that there are 
people who attended AA meetings for reasons other than AUD. We did not include use of 
alcohol pharmacotherapy such as disulfuram or acamprosate to identify prior AUD. We have 
found that these medications are used rarely among PLWH although hopefully this will 
improve in the future. While the clinical assessment has expanded to include Amharic, this 
study included only English and Spanish-speaking PLWH which may reduce 
generalizability to PLWH who do not speak English or Spanish and/or are not in care.
Conclusions
This study demonstrated that among current non-drinking PLWH in clinical care across the 
US, over a third had a prior AUD. This substantial number could have significant impacts on 
conclusions about health outcomes. We found key differences between non-drinking PLWH 
with and without a prior AUD with striking differences in former drug use with rates at least 
twice as high among those with vs. without a prior AUD. Despite these differences, many of 
those with a prior AUD who became current non-drinkers had excellent adherence and viral 
suppression and thus this serves as yet one more reason to encourage decreased alcohol use 
among those with an AUD and not withholding ART among those with a prior AUD. These 
results suggest that non-drinking PLWH are a heterogeneous group that needs further 
differentiation in studies and that prior AUD and other problem alcohol use should be 
included in behavioral health assessments as part of clinical care and research.
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Table 1
Prior alcohol use disorder as identified by two approaches: prior alcohol abuse/dependence diagnoses or 
reporting previously attending alcohol anonymous or other alcohol treatment among current non-drinkers with 
HIV in clinical care at 6 CNICS sites across the U.S. from 1/2013 to 3/2015 (N=2235)
AA meeting or other alcohol treatment
Alcohol abuse/dependence diagnoses No Yes Total
No 1436, 64% 524, 23% 88%
Yes 111, 5% 164, 7% 12%
Total 69% 31% 2235
-Prior alcohol abuse/dependence diagnoses identified in the electronic medical record
-AA meeting or other alcohol treatment identified as part of the clinical assessment.
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Table 4
Factors associated with prior alcohol use disorder in multivariate analyses among current non-drinking persons 
living with HIV in clinical care at 6 CNICS sites across the U.S. in 1/2013 to 3/2015
OR: 95% CI, p value
Sex
Female Ref
Male 1.53: 1.08–2.17, 0.02
Age (per year) 1.00: 0.99–1.01, 0.6
Race/ethnicity
White Ref
Black 0.95: 0.73–1.25, 0.7
Hispanic 1.16: 0.82–1.62, 0.4
Other 1.38: 0.88–2.17, 0.2
HIV transmission risk factor
MSM Ref
IDU* 1.54; 1.11–2.13, 0.01
Heterosexual 1.07: 0.77–1.49, 0.7
Other 0.82: 0.42–1.60, 0.6
Nadir CD4 cell count (per 100 cells/mm3) 1.02: 0.98–1.07, 0.3
Viral load (per log change) 0.98: 0.94–1.02, 0.3
Hepatitis C virus
No Ref
Yes 1.30: 0.96–1.77, 0.09
Depression
None Ref
Mild 1.18: 0.91–1.54, 0.2
Moderate 1.11: 0.84–1.47, 0.5
Severe 0.97: 0.58–1.62, 0.9
Methamphetamine/crystal use
 None Ref
 Past 1.53: 1.13–2.09, 0.01
 Current 1.09: 0.71–1.67, 0.7
Cocaine/crack use
 None Ref
 Past 3.00: 2.28–3.94, <0.001
 Current 3.74: 2.04–6.83, <0.001
Opioid/heroin use
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OR: 95% CI, p value
 None Ref
 Past 2.09: 1.53–2.86, <0.001
 Current 1.59: 0.77–3.30, 0.2
Marijuana use
 None Ref
 Past 1.91: 1.43–2.56, <0.001
 Current 1.02: 0.72–1.45, 0.9
Cigarette use
 Never Ref
 Past 1.47: 1.10–1.97, 0.01
 Current 2.00: 1.53–2.62, <0.001
Those with a prior alcohol use disorder including those with a previous alcohol use disorder in the electronic medical record or those who reported 
on the clinical assessment that they had ever been in alcohol treatment or attended Alcoholics Anonymous for an alcohol problem
AIDS Care. Author manuscript; available in PMC 2018 February 01.
